Media

Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.

https://investor.ironwoodpharma.com/press-releases/press-release-details/2018/Ironwood-Presents-Praliciguat-Phase-IIa-Study-Data-Showing-Positive-Impact-on-Metabolic-and-Cardiovascular-Clinical-Endpoints-at-the-American-Diabetes-Associations-78th-Scientific-Sessions/default.aspx

Ironwood has successfully completed the tender offer of VectivBio, a global clinical-stage biotechnology company
pioneering novel, transformational treatments for severe rare gastrointestinal conditions. For more information, click here